Ritlecitinib Clinical Trials
7 recruitingDrug
Phase 23Phase 31
Showing 1–7 of 7 trials
Recruiting
Phase 2
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
Hidradenitis Suppurativa
Pfizer240 enrolled54 locationsNCT07228390
Recruiting
Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US
Alopecia Areata
Pfizer300 enrolled1 locationNCT07226531
Recruiting
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Alopecia Areata
Pfizer850 enrolled58 locationsNCT06531109
Recruiting
Phase 2
Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
Celiac Disease
Massachusetts General Hospital40 enrolled1 locationNCT05636293
Recruiting
Phase 2
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
keloid
Icahn School of Medicine at Mount Sinai30 enrolled1 locationNCT06373458
Recruiting
Phase 3
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Vitiligo
Pfizer400 enrolled74 locationsNCT06163326
Recruiting
Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
Alopecia AreataJanus Kinase Inhibitors
Second Affiliated Hospital, School of Medicine, Zhejiang University150 enrolled1 locationNCT06573593